Summary. 1) The effect of hemin on heme synthesis was studied in vivo. Heme synthesis was measured by determining red cell 59Fe uptake and glycine-2-14C incorporation into red cell hemin in normal CF1 female mice.
Introduction
Recent evidence from in vitro studies suggests that an end product feedback control process may be important in the regulation of heme biosynthesis. 8-Aminolevulinic acid synthetase (ALAS) is the first and rate-limiting enzyme in the heme biosynthetic pathway (1) , and Burnham and Lascelles have shown an inhibitory effect of hemin on this enzyme in the microorganism Rhodopseudomonas spheroides (2) . Heady, Jacobs, and Deibel have demonstrated that the addition of hemin to cultures of Staphylococcus epidermidis inhibits the accumulation of coproporphyrin un-der conditions of impaired heme synthesis (3) . Recently Karibian and London have demonstrated an inhibitory effect of hemin on the utilization of glycine-2-14C for heme synthesis in rabbit reticulocytes (4) . The data from these in zitro experiments suggest that heme synthesis is at least in part regulated by a feedback control mechanism. An in vivo study of the effects of heme would clarify the physiologic significance of their results. The results presented in this communication indicate that heme inhibits heme synthesis itn vSvo.
Methods
Heme synthesis was measured in normal CF1 female mice (weight, 20 to 27 g) by determining the incorporation of glycine-2-"4C (SA, 21.9 mc per mmole) 1 into hemin crystallized from erythrocytes of the peripheral 1 New England Nuclear Corp., Boston, Mass., lot no. 148-21 1A-65.
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blood and by measuring red cell uptake of 'Fe2 (SA, 1.1 mc per mg).
Preparation of solutions. Heme was obtained commercially as the bovine hemin chloride 3 or prepared directly from human blood by the method of Labbe and Nishida (5) . One mg of hemin was dissolved in 0.05 ml 1 N NaOH and 1.0 ml distilled H20 and buffered with 0.05 ml 1 M Tris (pH 8.2); the pH of the alkaline hematin solution was adjusted to 7.5 with 1 N HC1 (6) . Control (solvent) solutions were similarly prepared except for the exclusion of hemin. In experiments using red cell 'Fe uptakes as a measure of heme synthesis, control solutions of ferric chloride and iron dextran were prepared with the total elemental iron calculated to equal the amount contained in the administered hemin. The ferric chloride was dissolved in 1 N HCl and diluted with H20 and NaCl, and the pH was increased to 6.0 with 1 M Tris. The dilutions of solutions were calculated to keep the NaCl concentration 0.15 to 0.20 mole per L. Solutions of iron dextran 4 were diluted with 0.9% NaCl. All solutions were prepared daily and were injected immediately after preparation. Injections were all into the tail vein on two successive days. On the third day the radioisotope was injected. Subsequent methods differed for the two radioisotopes.
Glycine-2-_4C uptake into hemin. Three ,uc of glycine-2-14C was injected intraperitoneally, and 80 hours after injection 0.4 ml of heparinized blood was obtained by 2E. R. Squibb, New York, N. Y. 3 Nutritional Biochemical Co., St. Louis, Mo. 4 Lakeside Laboratory, Milwaukee, Wisc. 100 80 OPM 60r intracardiac puncture. The blood was centrifuged at 800 g for 15 minutes. The plasma was removed and the packed red cell pellet washed three times with cold phosphate-buffered 0.9% NaCl, pH 7.4. The red cells were then lysed 'with 3.0 ml cold distilled water and 1.5 ml Drabkin's solution and left overnight. The stromata were removed the following day by centrifuging at 15,000 g for 20 minutes in the cold. Cold 0.1 N HCl was then added to bring the clear hemoglobin solution to approximately pH 2.0. The HCO was added dropwise with constant mixing. The solution was then added to an equal volume of cold 2-butanone and immediately and vigorously mixed for 30 to 45 seconds (7) . The volume of the heme (ketonic phase) was recorded and separated from the aqueous phase. The butanone was evaporated, and the crystals were isolated, washed twice with 50% acetic acid, twice with distilled H20, once with 95% ethyl alcohol, and once with ether. The purity of the crystals was tested by redissolving a small sample in 2-butanone. Approximately 1.5 jug was spotted in two regions at the origin on Whatman 1 chromatography paper, and chromatograms were developed for 20 hours in a 2,6-lutidine, H20, 1 N NH40H solvent (10: 2.8: 4.1) ascending system (8) . Controls of hemin chloride in butanone and aqueous alkaline hemin solutions were run simultaneously. The paper was divided and then sprayed with benzidine hydrochloride spray (9) except for the area above the second "test" spot, which after drying was isolated and cut into 1-cm squares from origin to front. The squares were counted by adding to a 20-ml glass counting vial 5 (Figure 1 ). The remaining dry hemin crystals were dissolved in 1.0 ml of pyridine, and a sample of the pyridine solution was used to determine the concentration of hemin spectrophotometrically after adding a few crystals of sodium hydrosulfite (Na2S204). The spectrum of the CN-ferriprotoporphyrin after the addition of pyridine and Na2S,04 is identical to the pyridine hemochromogen and presumably reflects conversion of the CN-ferriprotoporphyrin to the pyridine ferroprotoporphyrin (10) . Readings were also taken at several wavelengths with particular attention to values at 557 mj, 526 mfi, and 541 mnit, the a maximum, maximum, and the minimum, respectively. The spectrum obtained from these analyses was used as another criterion of purity of the crystals (Figure 2) . The values at the a maximum were used in calculations of the concentration.
A sample of the pyridine solution containing 5 to 15 mg of labeled hemin in 50 ,ul of pyridine was dissolved in 1 ml 1 M Hyaminemethanol 7 in glass counting vials. Sixteen ml scintillator solution was added, and the vials 6 were counted in a liquid spectrometer.8 Correction for quenching was made with toluene-'C internal standard, radioactivity 4.37 X 10" dpm per ml. 9 Red cell 'Fe uptake. After injections of hemin or control solutions on days 1 and 2, 0.5 1kc of Cls-'Fe was in-.
jected into the tail vein on day 3. At the same time 0.5 /Ac was also injected into a flask (standard) and diluted to 50 ml with distilled water. One-fourth of a milliliter of heparinized blood was obtained by intracardiac puncture at varying time intervals, and the radioactivity due to 'Fe was determined in a well type scintillation gamma counter.'0 A sample from the flask was also counted. The blood volume was calculated by multiplying total body weight by 6%, and the total red cell radioactivity was determined by multiplying counts per minute per milliliter by blood volume. The per cent red cell 'Fe uptake was calculated as per cent of the total counts injected (standard), and the mean value was determined from a group of six to ten animals. Separate groups of mice received the same solutions but were sacrificed for determination of plasma iron 1 immediately before the time 'Fe was to be injected (11) .
Studies with protoporphyrin. Protoporphyrin IX was prepared by ether extraction of the porphyrin after overnight hydrolysis of the dimethyl ester with 7 N HC1 (12) . The ether was allowed to evaporate, and the protoporphyrin crystals were prepared for injection as described above for hemin. The effect of protoporphyrin (100 emoles per kg) on the 48-hour red cell 'Fe uptake was studied in untreated mice and mice previously injected with hemin or with solvent control solutions. The solutions were given on 3 successive days in these experiments to avoid circulatory overload from the relatively large volume of solution.
Studies with 5-aminolevulinic acid (ALA) .12 As in the studies with protoporphyrin, the effect of ALA on the 48-hour red cell 'Fe uptake was studied in mice previously treated with hemin and in untreated controls. The ALA was dissolved in distilled H20, and the pH was increased to 5.0 with 1 N NaOH. A total of 5.4 mmoles per kg was given intraperitoneally in one injection at varying intervals after heme (or solvent) injection and before 'Fe. As in most of the previous experiments, the hemin was given over a 2-day period.
Bone 
Results
Red cell 59Fe uptakes. The total mouse heme synthesized per day may be calculated from the blood hemoglobin concentration, the per cent heme in hemoglobin, the total blood volume, and the red cell life-span. From data published on the mouse, the total heme synthesized in a 48-hour period is -approximately 20 to 30 amoles per kg (13, 14) . When this amount of heme was injected, there was no detectable effect on iron iron as in the administered hemin had no effect on iron when given 1 and 2 days before 59Fe injection, the same time the experimental animals had received hemin. (Figure 3) . The inhibition was found as long as 4 days after the last injection of hemin (Figure 4) . The value returned to control levels by the sixth day after the last hemin injection (not shown in the Figure) . The plasma iron values in the experimental heme group were not higher than in the control groups. The mean values in the mice injected with hemin (90 jPmoles per kg over 2 days) were 221 + 29.5 pug per 100 ml; in the solvent control group, 337 + 128.0 ,ug per 100 ml; and in the control mice injected with ferric chloride, 238 ± 43.9 pug per 100 ml ( Figure 6 ). The data when considered together tend to exclude the possibility that the effect of hemin on red cell 59Fe uptake is due to a dilution of the 59Fe pool with unlabeled iron from the injected and subsequently catabolized hemin. Effect of protoporphyrin. When equimolar amounts of protoporphyrin were given to animals simultaneously treated with hemin, the inhibitory effect of hemin on red cell 59Fe uptake was diminished by 64% (t = 4.45, p < 0.001) (15) . There was no effect from protoporphyrin alone ( Figure  7) . These results indicate that the effect of hemin is not through a dilution of the newly synthesized heme pool with unlabeled injected heme.
Effect of ALA. The experimental protocol and the results of studies with ALA are summarized in Table I (Table I) . Incorporation of glycine-2-14C into herein. The results of the counts of a typical paper chromatogram of the isolated hemin crystals are shown in Figure 1 . More than 95 % of the recovered radioactivity migrated with an Rf appropriate for hemin (0.62 to 0.63) in every sample. A typical absorption spectrum of the reaction product of the cyanide ferriprotoporphyrin crystals with pyridine followed by reduction with Na2S204 is shown in Figure 2 . These spectra were identical to the pattern with recrystallized hemin converted to the pyridine hemochromogen. The ratio of the millimolar extinction coefficient of hemin prepared as described at the a maximum to the minimum (E millimolar a maximum/E millimolar a minimum) was approximately 3.4. The value closely approximated the results reported by Paul, Theorell, and Akeson (16) . Results of the radioactivity of the paper chromatograms and the absorption spectrum of the isolated crystals outlined above demonstrate that the hemin crystals as prepared for counting radioactivity were relatively pure. Figure 8 illustrates the effects of hemin administration on the utilization of glycine-2-14C for heme synthesis. The mean specific activity in the control group was 3,339 ± 925 cpm per mg. The mean value in the mice injected with hemin was 1,273 ± 172 cpm per mg. When total radioactivity of the samples was measured rather than specific activity, the mean value of animals injected with hemin was decreased to 50% of the controls.
Morphologic studies. There was no observable difference in the bone marrow morphology or in reticulocyte counts in the experimental and control groups (Figure 9) .
Studies on the permeability of bone marrow cells to hemin-14C demonstrated that approximately 0.75%o of the total labeled hemin per 1 X 106 nucleated cells entered the cells at a hemin-14C concentration of 104 mole per L. The details of these results will be reported in a separate communication.
Discussion
The results of the experiments demonstrating an inhibitory effect of hemin on red cell 59Fe uptake may be interpreted as due to a dilution of the 59Fe pool by iron released from the administered and subsequently catabolized hemin. The lack of significant inhibition by a comparable amount of iron given as the inorganic ferric chloride or as the or- Each point is the mean of six different mice. there were significant dilution of the 59Fe pool, an elevation in plasma iron would be expected. However, the plasma iron values in the mice injected with hemin were not significantly different from controls ( Figure 6 ). Moreover, this explanation is not applicable to the results of the experiments with glycine-2-14C.
An alternative explanation is that the effect of hemin is through a dilution of the newly synthesized heme pool with the administered hemin itself. This could result in competition between the injected hemin and labeled heme for globin. The injected hemin by competing with the newly synthesized heme for globin sites would decrease the per cent of labeled molecules of heme joined to globin and subsequently of the radioactivity detected in the peripheral blood. This argument is particularly applicable to the results with glycine-2_14C in which the specific activity of hemin is measured rather than total radioactivity. However, total hemin-14C radioactivity was also measured and was found to be significantly less in mice injected with hemin than in controls. Moreover, in experiments in which the effect of protoporphyrin on red cell 59Fe uptake was studied, there was no effect on untreated mice. However, the administration of equimolar amounts of protoporphyrin to mice previously injected with hemin significantly diminished the inhibitory effect of hemin (t = 4.45, p < 0.001) (Figure 7 ). These results cannot be explained by a dilution mechanism. Furthermore, the data of Ostrow, Jandl, and Schmid indicate that labeled heme is rapidly catabolized. Half of the radioactivity was recovered within 2 to 5 hours after infusion of hemoglobin-14C (17) . In the experiments reported here, the radioactivity of peripheral red cells was not measured until at least 72 hours after hemin infusion with the exception of the one experiment in which the 24-hour red cell 59Fe uptake was measured.
It is possible that the inhibitory effect of hemin is a nonspecific noxious effect not limited to heme biosynthesis. The observations that heme produced minimal impairment in the utilization of ALA for heme synthesis (2, 4) and that heme stimulated globin synthesis (18) make this improbable.
In vivo studies of red cell 59Fe uptake and glycine-2-14C incorporation into red cell hemin measure not only the rate of heme synthesis but may reflect in part the rate of reticulocyte formation. It is conceivable then that the inhibitory effect of hemin observed in this study was due to a decrease in the rate of reticulocyte entrance into the peripheral blood. The normal bone marrow morphology and reticulocyte counts indicate that this is not a significant effect. The results are in keeping with a direct inhibitory effect of hemin on the formation of heme. The possibility that this effect is due to a catabolic product of heme or of some heme complex such as methemalbumin has not been ruled out.
Although the exact site has not been identified, the experiments with protoporphyrin demonstrate that the inhibitory effect of hemin on heme synthesis occurs before the formation of protoporphyrin, and therefore not on the enzyme chelating iron and protoporphyrin (ferrochelatase) (Figure 7) . Data published by others indicate that the site of inhibition is before the formation of ALA (2, 4) . These sites include the formation of succinate, the activation of glycine and succinate, and the condensation of glycine with succinyl-coenzyme A catalyzed by ALAS. There is no information on the former possibilities, and from the available evidence it appears that the site of inhibition may be ALAS. This enzyme is the first and rate-limiting enzyme of heme biosynthesis (1), and a direct inhibitory effect of heme on ALAS has been demonstrated in the bacterium Rhodopseudomonas spheroides (2) . It is of interest that heme may also be involved in the repression of ALAS formation. This has been recently demonstrated in a hepatic tryptophan pyrrolase system (19) and more directly by an inhibition of allylisopropylacetamide induction of ALAS activity in rats (20) . The results reported in this communication do not distinguish between an effect mediated through repression of enzyme synthesis and one of direct enzyme inhibition.
If heme inhibits ALAS, it would be expected that the incorporation of glycine-2-14C into red cells would be inhibited by heme, and this inhibition was observed (Figure 8 ). On the other hand, the utilization of ALA-14C for the synthesis of heme should not be affected by hemin. It would seem reasonable then to study the effect of hemin on the utilization of ALA-14C for heme synthesis. However, Schwartz has found that only 0.1 to 0.3%o of the total injected ALA-14C is incorporated into hemoglobin (21) . This suggests a relative impermeability of erythroid elements to ALA. Similar findings have also been reported by others (22-24). Very low ALA-14C incorporation into heme would preclude in vivo studies of the effect of hemin on ALA-14C incorporation into hemoglobin. On the other hand, it is possible to give pharmacologic amounts of unlabeled ALA in an attempt to overcome this relative impermeability. It would then be theoretically possible to bypass ALAS, the presumed site of hemin inhibition. If hemin inhibits ALAS, then the amount of free protoporphyrin available to chelate with iron would be diminished, and red cell iron uptakes would be comparatively reduced. The addition of ALA would increase protoporphyrin formation, and the red cell iron uptakes would be increased proportionate to the increase in hemoglobin synthesis. The results of such studies are shown in Table I . ALA did not diminish the inhibitory effect of hemin. This suggests that even with pharmacologic quantities (5.4 mmoles per kg) of ALA there is insignificant entrance into erythroid precursors or that the site of hemin inhibition of heme synthesis is not ALAS.
The uptake of hemin (104 M) into a mixed population of a bone marrow cell suspension (106 cells) was approximately 0.75% of the total hemin. Steady state conditions were achieved within 10 to 20 minutes of incubation, indicating a rapid influx of hemin. The rapidity with which influx of hemin equals efflux in an in vitro system is compatible with the in vitro demonstration of a rapid effect of hemin on heme synthesis (4 (26) , and Grayzel and associates clearly demonstrated that the preservation of polyribosomal integrity is due to hemin. Presumably, the effect of iron is due to chelation with protoporphyrin and the formation of heme (25) . In light of this evidence, the hypothesis proposed by London of a feedback control mechanism by which heme inhibits its own formation and stimulates globin synthesis is appealing (27) .
